Here's Why Zai Lab Limited (ZLAB) Fell in Q1
Baron Funds, an investment management company, released its “Baron Emerging Markets Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Source: insidermonkey.com
Page 3 - Zai Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Zai Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Zai Lab Today - Breaking & Trending Today
Qiming Venture Partners Promotes Alex Zhou to Managing Partner
SHANGHAI, May 23, 2024 /PRNewswire/ -- Qiming Venture Partners, a global-leading venture capital firm, is pleased to announce the promotion of Alex Zhou to Managing Partner. As a Qiming
Source: finanznachrichten.de
Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China
Drug-resistant Acinetobacter baumannii is a growing global health threat and high priority pathogen needing new antibiotics, according to World Health Organization China NMPA approval based on...
Source: marketscreener.com
Zai Lab, Innoviva: China Oks XACDURO For Hospital-Acquired, Ventilator-Associated Pneumonia In 18+
Zai Lab Ltd. (ZLAB) and Innoviva Specialty Therapeutics announced Monday that China's National Medical Products Administration or NMPA has approved Zai Lab's New Drug Application for XACDURO (sulbactam-durlobactam) to treat hospital-acquired and ventilator-associated pneumonia caused by Acinetobacter baumannii-calcoaceticus complex in China.
Source: rttnews.com
China's NMPA approves Zai Lab's XACDURO NDA for pneumonia
The NMPA's decision was based on the positive outcomes of the Phase III ATTACK trial.
Source: yahoo.com